MDxHealth SA (MDXH)
NASDAQ: MDXH · Real-Time Price · USD
3.340
-0.040 (-1.18%)
At close: Mar 10, 2026, 4:00 PM EDT
3.450
+0.110 (3.29%)
After-hours: Mar 10, 2026, 7:58 PM EDT
MDxHealth Revenue
In the year 2025, MDxHealth had annual revenue of $107.88M with 19.80% growth. MDxHealth had revenue of $29.55M in the quarter ending December 31, 2025, with 19.43% growth.
Revenue (ttm)
$107.88M
Revenue Growth
+19.80%
P/S Ratio
1.59
Revenue / Employee
$345,753
Employees
312
Market Cap
171.56M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 107.88M | 17.83M | 19.80% |
| Dec 31, 2024 | 90.05M | 19.86M | 28.29% |
| Dec 31, 2023 | 70.19M | 33.14M | 89.43% |
| Dec 31, 2022 | 37.05M | 14.82M | 66.62% |
| Dec 31, 2021 | 22.24M | 3.78M | 20.47% |
| Dec 31, 2020 | 18.46M | 6.68M | 56.64% |
| Dec 31, 2019 | 11.79M | -16.61M | -58.50% |
| Dec 31, 2018 | 28.40M | -12.11M | -29.90% |
| Dec 31, 2017 | 40.51M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Myriad Genetics | 824.50M |
| Castle Biosciences | 344.23M |
| Fulgent Genetics | 322.67M |
| FONAR | 106.03M |
| Prenetics Global | 92.39M |
| Biodesix | 88.50M |
| Burning Rock Biotech | 75.75M |
| Personalis | 69.65M |
MDXH News
- 12 days ago - MDxHealth SA (MDXH) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 26 days ago - Mdxhealth to Present Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on February 26 - GlobeNewsWire
- 2 months ago - MDxHealth Reports Preliminary Fourth Quarter and Full Year 2025 Revenues, Issues 2026 Revenue Guidance, and Amends Earnout Terms with Exact Sciences - GlobeNewsWire
- 2 months ago - Mdxhealth and University of Oxford to validate GPS test in largest randomized trial of treatment effectiveness in patients with localized prostate cancer - GlobeNewsWire
- 4 months ago - MDxHealth SA (MDXH) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Angle PLC Announces Strategy Update - Accesswire
- 7 months ago - Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne - GlobeNewsWire
- 8 months ago - Mdxhealth Appoints Michael Holder to Board of Directors and Announces Management Change - GlobeNewsWire